Dr. Reddy's Laboratories Limited (DRREDDY.NS)
INR 1172.1
(0.72%)
INR 1172.1
(0.72%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 387.51 Billion INR | 20.03% |
| 2022 | 322.85 Billion INR | 8.83% |
| 2021 | 296.65 Billion INR | 11.74% |
| 2020 | 265.49 Billion INR | 14.32% |
| 2019 | 232.24 Billion INR | 3.02% |
| 2018 | 225.42 Billion INR | -0.08% |
| 2017 | 225.6 Billion INR | 2.63% |
| 2016 | 219.82 Billion INR | 5.86% |
| 2015 | 207.65 Billion INR | 6.62% |
| 2014 | 194.76 Billion INR | 14.42% |
| 2013 | 170.22 Billion INR | -88.04% |
| 2012 | 1423.69 Billion INR | 1091.6% |
| 2011 | 119.47 Billion INR | 25.76% |
| 2010 | 95 Billion INR | 18.27% |
| 2009 | 80.33 Billion INR | -4.13% |
| 2008 | 83.79 Billion INR | -1.93% |
| 2007 | 85.44 Billion INR | -0.79% |
| 2006 | 86.12 Billion INR | 24.91% |
| 2005 | 68.94 Billion INR | 135.4% |
| 2004 | 29.28 Billion INR | 9.79% |
| 2003 | 26.67 Billion INR | 15.86% |
| 2002 | 23.02 Billion INR | 21.53% |
| 2001 | 18.94 Billion INR | 60.02% |
| 2000 | 11.83 Billion INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 465.95 Billion INR | 12.2% |
| 2024 Q1 | 415.29 Billion INR | 7.17% |
| 2023 Q3 | 372.84 Billion INR | 7.44% |
| 2023 Q2 | 347.02 Billion INR | 3.58% |
| 2023 FY | 387.51 Billion INR | 20.03% |
| 2023 Q4 | 387.51 Billion INR | 3.94% |
| 2023 Q1 | 335.04 Billion INR | 3.78% |
| 2022 Q4 | 322.85 Billion INR | 4.38% |
| 2022 FY | 322.85 Billion INR | 8.83% |
| 2022 Q3 | 309.3 Billion INR | 6.3% |
| 2022 Q1 | 295.97 Billion INR | -0.23% |
| 2022 Q2 | 290.97 Billion INR | -1.69% |
| 2021 Q2 | 278.5 Billion INR | 0.1% |
| 2021 FY | 296.65 Billion INR | 11.74% |
| 2021 Q1 | 278.21 Billion INR | 4.79% |
| 2021 Q4 | 296.65 Billion INR | 5.01% |
| 2021 Q3 | 282.49 Billion INR | 1.44% |
| 2020 Q3 | 252.34 Billion INR | -0.41% |
| 2020 Q4 | 265.49 Billion INR | 5.21% |
| 2020 FY | 265.49 Billion INR | 14.32% |
| 2020 Q1 | 251.24 Billion INR | 8.18% |
| 2020 Q2 | 253.37 Billion INR | 0.85% |
| 2019 Q2 | 233.86 Billion INR | 2.98% |
| 2019 Q3 | 217.89 Billion INR | -6.83% |
| 2019 FY | 232.24 Billion INR | 3.02% |
| 2019 Q4 | 232.24 Billion INR | 6.58% |
| 2019 Q1 | 227.09 Billion INR | 0.74% |
| 2018 Q2 | 234.23 Billion INR | 1.45% |
| 2018 Q1 | 230.88 Billion INR | 2.34% |
| 2018 Q4 | 225.42 Billion INR | -0.55% |
| 2018 Q3 | 226.67 Billion INR | -3.23% |
| 2018 FY | 225.42 Billion INR | -0.08% |
| 2017 Q4 | 225.6 Billion INR | -0.16% |
| 2017 FY | 225.6 Billion INR | 2.63% |
| 2017 Q3 | 225.95 Billion INR | 1.77% |
| 2017 Q2 | 222.01 Billion INR | 1.66% |
| 2017 Q1 | 218.38 Billion INR | -0.65% |
| 2016 Q3 | 227.18 Billion INR | 3.07% |
| 2016 Q2 | 220.41 Billion INR | 12.73% |
| 2016 Q4 | 219.82 Billion INR | -3.24% |
| 2016 Q1 | 195.52 Billion INR | -5.84% |
| 2016 FY | 219.82 Billion INR | 5.86% |
| 2015 Q2 | 202.48 Billion INR | 0.64% |
| 2015 Q4 | 207.65 Billion INR | -0.11% |
| 2015 Q1 | 201.2 Billion INR | 3.31% |
| 2015 FY | 207.65 Billion INR | 6.62% |
| 2015 Q3 | 207.88 Billion INR | 2.66% |
| 2014 FY | 194.76 Billion INR | 14.42% |
| 2014 Q3 | 184.39 Billion INR | 4.58% |
| 2014 Q2 | 176.31 Billion INR | 1.6% |
| 2014 Q1 | 173.54 Billion INR | 1.95% |
| 2014 Q4 | 194.76 Billion INR | 5.62% |
| 2013 Q3 | 168.11 Billion INR | 4.33% |
| 2013 Q1 | 150.93 Billion INR | -89.4% |
| 2013 Q4 | 170.22 Billion INR | 1.25% |
| 2013 Q2 | 161.14 Billion INR | 6.76% |
| 2013 FY | 170.22 Billion INR | -88.04% |
| 2012 FY | 1423.69 Billion INR | 1091.6% |
| 2012 Q4 | 1423.69 Billion INR | 940.63% |
| 2012 Q2 | 130.55 Billion INR | 3.09% |
| 2012 Q1 | 126.63 Billion INR | 5.99% |
| 2012 Q3 | 136.81 Billion INR | 4.8% |
| 2011 FY | 119.47 Billion INR | 25.76% |
| 2011 Q4 | 119.47 Billion INR | -2.41% |
| 2011 Q3 | 122.43 Billion INR | 13.57% |
| 2011 Q2 | 107.8 Billion INR | 10.06% |
| 2011 Q1 | 97.95 Billion INR | 3.1% |
| 2010 Q1 | 81.86 Billion INR | 1.91% |
| 2010 Q3 | 84.02 Billion INR | 0.78% |
| 2010 Q4 | 95 Billion INR | 13.07% |
| 2010 FY | 95 Billion INR | 18.27% |
| 2010 Q2 | 83.36 Billion INR | 1.84% |
| 2009 Q3 | 72.61 Billion INR | -12.17% |
| 2009 Q1 | 76.22 Billion INR | -9.03% |
| 2009 Q4 | 80.33 Billion INR | 10.62% |
| 2009 Q2 | 82.67 Billion INR | 8.46% |
| 2009 FY | 80.33 Billion INR | -4.13% |
| 2008 FY | 83.79 Billion INR | -1.93% |
| 2008 Q4 | 83.79 Billion INR | -13.03% |
| 2008 Q1 | 90.99 Billion INR | 6.5% |
| 2008 Q2 | 95.56 Billion INR | 5.03% |
| 2008 Q3 | 96.34 Billion INR | 0.81% |
| 2007 Q4 | 85.44 Billion INR | 6.57% |
| 2007 Q3 | 80.18 Billion INR | -0.82% |
| 2007 Q2 | 80.84 Billion INR | 3.18% |
| 2007 Q1 | 78.35 Billion INR | -9.02% |
| 2007 FY | 85.44 Billion INR | -0.79% |
| 2006 Q3 | 87.09 Billion INR | 5.2% |
| 2006 Q4 | 86.12 Billion INR | -1.11% |
| 2006 Q1 | 77.62 Billion INR | 12.59% |
| 2006 FY | 86.12 Billion INR | 24.91% |
| 2006 Q2 | 82.78 Billion INR | 6.64% |
| 2005 FY | 68.94 Billion INR | 135.4% |
| 2005 Q3 | 32.81 Billion INR | 3.63% |
| 2005 Q4 | 68.94 Billion INR | 110.11% |
| 2005 Q1 | 30.94 Billion INR | 5.65% |
| 2005 Q2 | 31.66 Billion INR | 2.34% |
| 2004 Q4 | 29.28 Billion INR | 12.21% |
| 2004 FY | 29.28 Billion INR | 9.79% |
| 2004 Q1 | 29.1 Billion INR | 9.1% |
| 2004 Q3 | 26.1 Billion INR | -6.63% |
| 2004 Q2 | 27.95 Billion INR | -3.95% |
| 2003 Q1 | 24.34 Billion INR | 5.75% |
| 2003 Q4 | 26.67 Billion INR | 4.02% |
| 2003 Q2 | 25.18 Billion INR | 3.44% |
| 2003 Q3 | 25.64 Billion INR | 1.82% |
| 2003 FY | 26.67 Billion INR | 15.86% |
| 2002 FY | 23.02 Billion INR | 21.53% |
| 2002 Q3 | 22.29 Billion INR | 4.14% |
| 2002 Q4 | 23.02 Billion INR | 3.3% |
| 2002 Q1 | 20.88 Billion INR | 10.25% |
| 2002 Q2 | 21.4 Billion INR | 2.47% |
| 2001 FY | 18.94 Billion INR | 60.02% |
| 2001 Q1 | 15.38 Billion INR | 0.0% |
| 2001 Q2 | 17.07 Billion INR | 10.96% |
| 2001 Q4 | 18.94 Billion INR | 5.35% |
| 2001 Q3 | 17.98 Billion INR | 5.32% |
| 2000 FY | 11.83 Billion INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Eris Lifesciences Limited | 70.48 Billion INR | -449.762% |
| Shilpa Medicare Limited | 30.93 Billion INR | -1152.804% |
| Solara Active Pharma Sciences Limited | 23.46 Billion INR | -1551.402% |
| J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | -870.219% |
| Aarey Drugs & Pharmaceuticals Limited | 3.04 Billion INR | -12605.836% |
| Aarti Pharmalabs Limited | 25.82 Billion INR | -1400.786% |
| Alkem Laboratories Limited | 155.74 Billion INR | -148.809% |
| Alembic Pharmaceuticals Limited | 64.45 Billion INR | -501.215% |
| AstraZeneca Pharma India Limited | 10.78 Billion INR | -3494.692% |
| Divi's Laboratories Limited | 154.7 Billion INR | -150.496% |
| Bafna Pharmaceuticals Limited | 1.47 Billion INR | -26140.1% |
| Bal Pharma Limited | 3.2 Billion INR | -11995.234% |
| Aurobindo Pharma Limited | 450.71 Billion INR | 14.022% |
| Bliss GVS Pharma Limited | 12.13 Billion INR | -3092.422% |
| Brooks Laboratories Limited | 904.45 Million INR | -42745.518% |
| FDC Limited | 24.68 Billion INR | -1470.113% |
| Granules India Limited | 55.2 Billion INR | -601.9% |
| Hester Biosciences Limited | 6.62 Billion INR | -5750.679% |
| Ind-Swift Limited | 6.54 Billion INR | -5821.085% |
| Ipca Laboratories Limited | 111.01 Billion INR | -249.075% |
| Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | -17751.556% |
| Jubilant Pharmova Limited | 115.48 Billion INR | -235.557% |
| Laurus Labs Limited | 83.87 Billion INR | -362.044% |
| Medico Remedies Limited | 961.95 Million INR | -40184.505% |
| Morepen Laboratories Limited | 12.93 Billion INR | -2896.57% |
| Orchid Pharma Limited | 15.53 Billion INR | -2393.883% |
| Vaishali Pharma Limited | 799.55 Million INR | -48366.588% |
| Sequent Scientific Limited | 15.4 Billion INR | -2415.723% |
| Sigachi Industries Limited | 6.94 Billion INR | -5482.574% |
| Suven Pharmaceuticals Limited | 22.54 Billion INR | -1619.18% |
| Valiant Laboratories Limited | 3.42 Billion INR | -11208.21% |
| Windlas Biotech Limited | 6.26 Billion INR | -6088.347% |
| ZIM Laboratories Limited | 4.46 Billion INR | -8572.754% |
| Zydus Lifesciences Limited | 292.8 Billion INR | -32.345% |
| Aarti Drugs Limited | 24.32 Billion INR | -1493.177% |
| Ajanta Pharma Limited | 46.38 Billion INR | -735.458% |
| Alembic Limited | 23.28 Billion INR | -1564.046% |
| Amrutanjan Health Care Limited | 3.66 Billion INR | -10462.795% |
| Bajaj HealthCare Limited | 7.65 Billion INR | -4964.749% |
| Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -82205.815% |
| Caplin Point Laboratories Limited | 26.97 Billion INR | -1336.646% |
| Glenmark Life Sciences Limited | 28.5 Billion INR | -1259.516% |
| Hikal Limited | 24.87 Billion INR | -1458.087% |
| Ind-Swift Laboratories Limited | 11.65 Billion INR | -3226.031% |
| Kilitch Drugs (India) Limited | 2.4 Billion INR | -16042.44% |
| Mangalam Drugs & Organics Limited | 3.33 Billion INR | -11522.372% |
| Medicamen Biotech Limited | 2.94 Billion INR | -13057.505% |
| Nectar Lifesciences Limited | 21.91 Billion INR | -1668.636% |
| Neuland Laboratories Limited | 18.32 Billion INR | -2014.625% |
| Par Drugs and Chemicals Limited | 1.01 Billion INR | -38037.369% |
| RPG Life Sciences Limited | 5.12 Billion INR | -7455.872% |
| Unichem Laboratories Limited | 31.69 Billion INR | -1122.707% |
| Venus Remedies Limited | 6.26 Billion INR | -6082.187% |
| Wanbury Limited | 3.43 Billion INR | -11181.682% |
| Wockhardt Limited | 76.49 Billion INR | -406.626% |
| Innova Captab Limited | 13.2 Billion INR | -2833.784% |
| Procter & Gamble Health Limited | 7.94 Billion INR | -4778.367% |
| Themis Medicare Limited | 5.66 Billion INR | -6741.573% |
| IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | -1626.6% |
| Mankind Pharma Limited | 119.63 Billion INR | -223.924% |
| Glenmark Pharmaceuticals Limited | 143.58 Billion INR | -169.885% |
| Sakar Healthcare Limited | 3.88 Billion INR | -9870.64% |
| Albert David Limited | 4.97 Billion INR | -7681.619% |
| Lupin Limited | 239.97 Billion INR | -61.485% |
| Gufic Biosciences Limited | 10.92 Billion INR | -3446.94% |
| Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 54.657% |
| Lincoln Pharmaceuticals Limited | 7 Billion INR | -5433.676% |
| Syncom Formulations (India) Limited | 4.04 Billion INR | -9476.293% |
| Piramal Enterprises Limited | 826.05 Billion INR | 53.088% |
| Torrent Pharmaceuticals Limited | 150.61 Billion INR | -157.299% |
| NATCO Pharma Limited | 69.06 Billion INR | -461.108% |
| Suven Life Sciences Limited | 2.84 Billion INR | -13501.766% |
| Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -21649.328% |
| Strides Pharma Science Limited | 58.39 Billion INR | -563.586% |
| Indoco Remedies Limited | 21.44 Billion INR | -1706.838% |
| Alpa Laboratories Limited | 1.82 Billion INR | -21119.713% |
| Lasa Supergenerics Limited | 1.5 Billion INR | -25585.778% |
| Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | -7424.037% |